Sulfobutyl Ether Beta-Cyclodextrin Sodium: Exceptional Solubility Enhancer & Versatile Excipient
ProcurenetShort description
Sulfobutyl Ether Beta-Cyclodextrin Sodium (CAS NO:182410-00-0) is a remarkable excipient, amplifying compound solubility in drugs. Crucial features include:
- Enhanced Solubility: Amplifies solubility by 10 to 25,000 times.
- Excellent Biocompatibility: Allows varied administration methods such as injection, oral, nasal, ocular, topical, and inhalation.
- Superior Stability: Interacting with this substance boosts drug substance stability, improving solubility, and resisting degradation.
- Safety Profile: Rapid elimination from kidneys with comprehensive safe data from toxicity studies.
- Fast Delivery: Ideal for the European market, including various quantities with a next-day delivery strategy.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Sulfobutyl Ether Beta-Cyclodextrin Sodium: Enhanced Solubility and Versatile Administration
Sulfobutyl Ether Beta-Cyclodextrin Sodium (CAS NO:182410-00-0) offers a groundbreaking solution as an excipient for the pharmaceutical industry. Known for its exceptional quality and unmatched functionalities, the product has carved a niche for itself in the market.
As a component in nitrogenous drugs, it exhibits significant encapsulation properties and an affinity for unique substances, hence enhancing the solubility of compounds in drug solutions by 10 to 25,000 times.
Sulfobutyl Ether Beta-Cyclodextrin Sodium offers an unbeatable advantage with its versatile administration methods. It can be successfully used in methods that include injection, oral, ocular, nasal, topical, and inhalation. This versatility in drug administration widens the application spectrum of pharmaceutical products, adding substantial value.
The safety profile of Sulfobutyl Ether Beta-Cyclodextrin Sodium is impeccable. The kidneys quickly and completely eliminate it post-administration. Its user-friendly and safe profile, backed by data from comprehensive in vitro and in vivo toxicity studies, marks its approval for use in human pharmaceutical preparations.
The product comes with superior stability, the interaction with Beta-Cyclodextrin Sodium creates an environment that protects drug substances. This attribute ensures excellent water solubility and stability, mitigating the risk of degradation or chemical alteration.
Key Features:
- Incredible enhancement of solubility up to 25,000 times
- Promotes versatile administration methods
- Backed by a robust safety and non-toxicity profile
- Furnishes superior stability and protective attributes
